Education
About Us
Working with TipRanks
Follow Us
Bernadette Connaughton Insider Profile
4 Followers
Bernadette Connaughton, Director at Halozyme, holds 42.12K shares in Halozyme (Ticker: HALO), holds 0.00 shares in Syneos Health (Ticker: SYNH), holds ― shares in Editas Medicine (Ticker: EDIT).
Bernadette Connaughton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bernadette Connaughton holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Bernadette Connaughton
Bernadette Connaughton's Trading History
Halozyme
Dec 01, 2025
Director
Uninformative Sell
59.36K
$2.88M
Syneos Health
Sep 28, 2023
―
Uninformative Sell
426.35K
$0.00
Editas Medicine
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Bernadette Connaughton's performance on stock
You May Also Like
Bernadette Connaughton insider profile FAQ
What is the percentage of profitable transactions made by Bernadette Connaughton?
The percentage of profitable transactions made by Bernadette Connaughton is ―.
What is the average return per transaction made by Bernadette Connaughton?
The average return per transaction made by Bernadette Connaughton is ―.
What stocks does Bernadette Connaughton hold?
Bernadette Connaughton holds: HALO, SYNH, EDIT stocks.
What was Bernadette Connaughton’s latest transaction?
Bernadette Connaughton latest transaction was an Uninformative Sell of $59.36K.
What was Bernadette Connaughton's most profitable transaction?
Bernadette Connaughton’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Bernadette Connaughton's role in Halozyme?
Bernadette Connaughton's role in Halozyme is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.